In this issue:
Patient satisfaction with citrate-free ixekizumab injection
Efficiency frontiers to align prices and clinical benefits
Serum 25-hydroxyvitamin D levels and psoriasis
Determinants of biologic survival in moderate-to-severe psoriasis
Bimekizumab in psoriasis
The complement system and subclinical atherosclerosis in psoriasis
Effect of methotrexate on adalimumab response in psoriasis
Uveitis prevalence and risk factors in psoriasis
IL-17a inhibitors in psoriasis and tuberculosis infection
Five-year ixekizumab treatment in psoriasis
Please login below to download this issue (PDF)